Abstract
AbstractIn recent years, probiotics and their derivatives have been recognized as important therapeutic agents in the fight against cancer. Therefore, this study aimed to investigate the anticancer effects of membrane vesicles (MVs) from Lentilactobacillus buchneri strain HBUM07105 probiotic isolated from conventional and unprocessed yogurt in Arak province, Iran, against gastric and colon cancer cell lines. The MVs were prepared from the cell-free supernatant (CFS) of L. buchneri and characterized using field-emission scanning electron microscopy (FE-SEM) and transmission electron microscopy (TEM) and SPS-PAGE techniques. The anticancer activity of MVs was evaluated using MTT, flow cytometry, qRT-PCR techniques, and a scratch assay. The study investigated the anti-adenocarcinoma effect of MVs isolated from L. buchneri on a human gastric adenocarcinoma cell line (AGS) and a human colorectal adenocarcinoma cell line (HT-29) at 24, 48, and 72-h time intervals. The results demonstrated that all prepared concentrations (12.5, 25, 50, 100, and 200 µg/mL) of MVs reduced the viability of both types of human adenocarcinoma cells after 24, 48, and 72 h of treatment. The analysis of the apoptosis results revealed that the percentage of AGS and HT-29 cancer cells in the early and late stages of apoptosis was significantly higher after 24, 48, and 72 h of treatment compared to the untreated cancer cells. After treating both AGS and HT-29 cells with the MVs, the cells were arrested in the G0/G1 phase. These microvesicles demonstrate apoptotic activity by increasing the expression of pro-apoptotic genes (BAX, CASP3, and CASP9). According to the scratch test, MVs can significantly decrease the migration of HT-29 and AGS cancer cells after 24, 48, and 72 h of incubation compared to the control groups. The MVs of L. buchneri can also be considered a potential option for inhibiting cancer cell activities.
Publisher
Springer Science and Business Media LLC
Reference84 articles.
1. Zendeboodi, F., Khorshidian, N., Mortazavian, A. M. & da Cruz, A. G. Probiotic: Conceptualization from a new approach. Curr. Opin. Food Sci. 32, 103–123 (2020).
2. Bermudez-Brito, M., Plaza-Díaz, J., Muñoz-Quezada, S., Gómez-Llorente, C. & Gil, A. Probiotic mechanisms of action. Ann. Nutr. Metab. 61(2), 160–174 (2012).
3. Cremon, C., Barbaro, M. R., Ventura, M. & Barbara, G. Pre-and probiotic overview. Curr. Opin. Pharmacol. 43, 87–92 (2018).
4. Tamime, A. Y., Saarela, M., Sondergaard, A. K., Mistry, V. & Shah, N. Production and maintenance of viability of probiotic microorganisms in dairy products. Probiot. Dairy Prod. 3, 39–63 (2005).
5. Haghshenas, B., Kiani, A. & Nami, Y. Probiotic potential and safety evaluation of lactic acid bacteria isolated from colostrum. J. Biosaf. 14(3), 37–60 (2021).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献